| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 10,044 | 12,314 | ||
| Accounts receivable | 169 | 363 | ||
| Inventory | 272 | - | ||
| Prepaid expenses | 350 | 430 | ||
| Other current assets | 145 | 288 | ||
| Total current assets | 10,980 | 13,395 | ||
| Right-of-use operating asset | 213 | 235 | ||
| Property and equipment, net | 13 | 13 | ||
| Total assets | 11,206 | 13,643 | ||
| Accounts payable | 869 | 671 | ||
| Accrued expenses | 1,015 | 885 | ||
| Total current liabilities | 1,884 | 1,556 | ||
| Common stock warrant liability | 1,110 | 1,285 | ||
| Operating lease liability, net of current portion | 134 | 161 | ||
| Total liabilities | 3,128 | 3,002 | ||
| Common stock, 0.0001 par value, 250,000,000 shares authorized 36,649,916 and 24,034,672 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 4 | 4 | ||
| Additional paid-in capital | 66,520 | 66,171 | ||
| Accumulated deficit | -58,446 | -55,534 | ||
| Total convertible preferred stock and stockholders equity | 8,078 | 10,641 | ||
| Total liabilities, convertible preferred stock and stockholders equity | 11,206 | 13,643 | ||
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)